HS-20093 Clinical Trials
9 recruitingDrug
Phase 14Phase 24Phase 31
Showing 1–9 of 9 trials
Recruiting
Phase 1
Evaluation of the Effect of Itraconazole on the Pharmacokinetics of HS-20093 in Patients With Advanced Solid Tumors
Advanced Solid Tumors
Hansoh BioMedical R&D Company18 enrolled1 locationNCT07186452
Recruiting
Phase 1
Phase Ib Study of HS-20093+HRS-5041 in Patients With Advanced Prostate Cancer
Advanced Prostate Cancer
Hansoh BioMedical R&D Company63 enrolled1 locationNCT07115446
Recruiting
Phase 1
ARTEMIS-102: HS-20093 Combinations in Patients with Advanced Metastatic Colorectal Cancer
Metastatic Colorectal Cancer (CRC)
Hansoh BioMedical R&D Company560 enrolled1 locationNCT06825624
Recruiting
Phase 2
HS-20093 in Patients with Advanced Esophageal Carcinoma and Other Advanced Solid Tumors
Advanced Solid Tumor
Hansoh BioMedical R&D Company220 enrolled21 locationsNCT06112704
Recruiting
Phase 3
ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer
Small Cell Lung Cancer
Hansoh BioMedical R&D Company460 enrolled9 locationsNCT06498479
Recruiting
Phase 2
ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas
SarcomaOsteosarcoma
Hansoh BioMedical R&D Company170 enrolled11 locationsNCT05830123
Recruiting
Phase 2
ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
Head and Neck Squamous Cell Carcinoma
Hansoh BioMedical R&D Company170 enrolled25 locationsNCT06007729
Recruiting
Phase 2
ARTEMIS-003: HS-20093 in Patients With Metastatic Castrate-resistant Prostate Cancer (mCRPC) and Advanced Solid Tumors
Metastasis Castration Resistant Prostate Cancer(mCRPC)
Hansoh BioMedical R&D Company120 enrolled15 locationsNCT06001255
Recruiting
Phase 1
ARTEMIS-101: A Study of HS-20093 Combinations in Patients With Advanced Solid Tumors
Advanced Solid Tumor
Hansoh BioMedical R&D Company610 enrolled1 locationNCT06332170